Point Of Care Infectious Disease Testing Market (2024 - 2030) Size, Share & Trends Analysis Report By Technology, By Disease (HIV POC, Clostridium Difficile POC), By End-use, By Region, And Segment Forecasts

Market Segmentation

Point Of Care Infectious Disease Testing Technology Outlook (Revenue, USD Billion, 2018 - 2030)
- Lateral Flow Immunoassay
- Agglutination Test
- Flow-through test/Immunoconcentration Assay
- Molecular Diagnostics
- Others
Point Of Care Infectious Disease Testing Disease Outlook (Revenue, USD Billion, 2018 - 2030)
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Pneumonia Or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB & Drug-resistant TB POC
- HSV POC
- COVID-19
- Other Infectious Diseases
Point Of Care Infectious Disease Testing End Use Outlook (Revenue, USD Billion, 2018 - 2030)
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Point Of Care Infectious Disease Testing Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - U.S.
  - Canada
  - Mexico
- Europe
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - Denmark
  - Sweden
  - Norway
- Asia Pacific
  - Japan
  - China
  - India
  - Australia
  - South Korea
  - Thailand
- Latin America
  - Brazil
  - Argentina
- Middle East and Africa (MEA)
  - South Africa
  - Saudi Arabia
  - UAE
  - Kuwait

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments